Sale of 422 shares at $8.63 per share.
Reporting Person Aguirre Jarrad Mattieu · Officer Title Chief Medical Officer · Transaction Code S
Traded Oct 12, 2026 · Disclosed Oct 13, 2026
Source: SEC Form 4 · 0002150331-26-000003 · filed 2026-10-13 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Lyell Immunopharma, Inc. (LYEL)." Disclosed 2026-10-13. https://desqlong.com/cards/0002150331-26-000003-1 (retrieved 2026-10-14).